
| 2019 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2011 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 5
As coordinator: 1
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0.25*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2021 | 0 | 10.379.596 | 819.158 | 2 | ||
| 2019 | 0 | 5.982.255 | 1.111.540 | 1 | ||
| 2013 | 0 | 3.036.614 | 378.437 | 1 | ||
| 2011 | 1.410.405 | 0 | 498.425 | 1 | ||
Total number of partners: 35
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 35
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2021-02-01 | A Personalised Living Cell Synthetic Computing Circuit for Sensing and Treating Neurodegenerative Disorders | PRIME | participant | 4.401.253 | 7 |
| 2021-01-01 | Edge AI-deployed DIGItal Twins for PREDICTing disease progression and need for early intervention in infectious and cardiovascular diseases beyond COVID-19 | DIGIPREDICT | participant | 5.978.344 | 10 |
| 2019-01-01 | Next-generation theranostics of brain pathologies with autonomous externally controllable nanonetworks: a trans-disciplinary approach with bio-nanodevice interfaces | GLADIATOR | participant | 5.982.255 | 7 |
| 2013-10-01 | "Innovative, mechanistic-based strategies for delivery of therapeutic macromolecules across cellular and biological barriers" | PATHCHOOSER | participant | 3.036.614 | 9 |
| 2011-11-01 | Management of Resistance to Tyrosine Kinase Inhibitors with Advanced Nanosystems | NANORESISTANCE | coordinator | 1.410.405 | 7 |